Home » Topics » Regulatory

Regulatory
RSS

Matrix selects distribution partner for Italy

March 5, 1997

Imiquimod for postviral asthma-like syndrome

Feb. 25, 1997

Phase I study of pentosan polysulfate in cancer patients

Feb. 25, 1997

Positive clinical results for doxazosin as BPH Rx

Feb. 21, 1997

Centocor seeks expansion of ReoPro indications

Feb. 21, 1997

Transdermal buspirone pivotal trials

Feb. 21, 1997

Schering-Plough seeks FDA approval for psoriasis treatment

Feb. 20, 1997

Antidepressant with minimal impact on sexual function introduced

Feb. 18, 1997

Immunomedics' LeukoScan approved for European market

Feb. 18, 1997

New dosage strengths of Coumadin available

Feb. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.